Journal of Clinical Microbiology, February 2006, p. 571-579, Vol. 44, No. 2
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.2.571-579.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA
Wim G. V. Quint,1
Sonia R. Pagliusi,2
Nico Lelie,3
Ethel-Michele de Villiers,4
Cosette M. Wheeler,5* and
the World Health Organization Human Papillomavirus DNA International Collaborative Study Group
Delft Diagnostic Laboratory, Delft, The Netherlands,1
Initiative for Vaccine Research, Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland,2
Viral Quality Control Laboratory, Central Laboratory for Blood Transfusion, Diagnostic Division, Alkmaar, The Netherlands,3
Reference Center for Papillomaviruses, Division for the Characterization of Tumorviruses, Deutsches Krebsforschungszentrum, Heidelberg, Germany,4
Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, Albuquerque, New Mexico5
Received 18 August 2005/
Returned for modification 23 October 2005/
Accepted 14 November 2005
Twenty-nine laboratories in 12 countries participated in a study to assess the performance of various human papillomavirus (HPV) detection assays through the use of a recombinant HPV DNA standard reagent panel. The panel was designed by a group of HPV experts, and samples were prepared and distributed by the World Health Organization International Laboratory for Standards and Biologicals in The Netherlands. Each panel consisted of 24 coded samples including a dilution series for HPV types 16 and 18, alone or in combination with five other high-risk (HR) HPV types including HPV types 31, 33, 35, 45, and 52, the low-risk HPV type 6, and a negative control. Qualitative assays were generally consistent across laboratories, and most invalid results reflected a lack of HPV test sensitivity. The combined data sets had a proficiency for HPV 16 of 62.5% (15/24) and for HPV 18 of 73.9% (17/23). HPV 31 was the least accurately detected by participating laboratories. Approximately half of participating laboratories failed to detect high concentrations of HPV 31 and, to a lesser extent, to detect HPV types 35, 52, and 6. The panel sample materials offer a source of renewable and reproducible material that could be used in the future development of international standard reagents for calibration of HPV DNA assays and kits.
* Corresponding author. Mailing address: Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, Albuquerque, NM 87131-5276. Phone: (505) 272-5785. Fax: (505) 277-0265. E-mail: cwheeler{at}salud.unm.edu.
Supplemental material for this article may be found at http://jcm.asm.org/.
Journal of Clinical Microbiology, February 2006, p. 571-579, Vol. 44, No. 2
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.2.571-579.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Castle, P. E., Gravitt, P. E., Solomon, D., Wheeler, C. M., Schiffman, M.
(2008). Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study. J. Clin. Microbiol.
46: 109-117
[Abstract]
[Full Text]
-
Soderlund-Strand, A., Dillner, J., Carlson, J.
(2008). High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry. Clin. Chem.
54: 86-92
[Abstract]
[Full Text]
-
Brukner, I., El-Ramahi, R., Gorska-Flipot, I., Krajinovic, M., Labuda, D.
(2007). An in vitro selection scheme for oligonucleotide probes to discriminate between closely related DNA sequences. Nucleic Acids Res
35: e66-e66
[Abstract]
[Full Text]
-
Payan, C., Ducancelle, A., Aboubaker, M. H., Caer, J., Tapia, M., Chauvin, A., Peyronnet, D., Le Hen, E., Arab, Z., Legrand, M.-C., Tran, A., Postec, E., Tourmen, F., Avenel, M., Malbois, C., De Brux, M.-A., Descamps, P., Lunel, F.
(2007). Human Papillomavirus Quantification in Urine and Cervical Samples by Using the Mx4000 and LightCycler General Real-Time PCR Systems. J. Clin. Microbiol.
45: 897-901
[Abstract]
[Full Text]
-
Huang, S.-L., Chao, A., Hsueh, S., Chao, F.-Y., Huang, C.-C., Yang, J.-E., Lin, C.-Y., Yan, C.-C., Chou, H.-H., Huang, K.-G., Huang, H.-J., Wu, T.-I, Tseng, M.-J., Qiu, J.-T., Lin, C.-T., Chang, T.-C., Lai, C.-H.
(2006). Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-Based Assay for Detection of Human Papillomavirus DNA in Cervical Swab Samples.. J. Clin. Microbiol.
44: 1733-1739
[Abstract]
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.